A partir de cette page vous pouvez :
Retourner au premier écran avec les catégories... | Votre compte |
Titre : | WHO classification of tumours of haematopoietic and lymphoid tissues |
Type de document : | texte imprimé |
Mention d'édition : | 4th ed. |
Editeur : | Lyon (Lyon) : International agency for research on cancer, 2008 |
Collection : | World health organization classification of tumours |
ISBN/ISSN/EAN : | 978-92-832-2431-0 |
Format : | 1 vol. (439 p.) / ill. / 27 cm |
Note générale : | Ce livre transcrit les réflexions du groupe de travail réuni du 25 au 27 octobre 2007, a Lyon, pour une conférence de consensus Bibliogr. p. 380-428 |
Langues: | Anglais |
Mots-clés: | Hémopathies malignes;Classification;Congrès* |
Résumé : |
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues is the second volume of the 4th Edition of the WHO series on histological and genetic typing of human tumours. This authoritative, concise reference book provides an international standard for oncologists and pathologists and will serve as an indispensable guide for use in the design of studies monitoring response to therapy and clinicat outcome. Diagnostic criteria, pathological features, and associated genetic alterations are described in a strictly diseaseoriented manner. Sections on all recognized neoplasms and their variants incluae new ICD-0 codes, incidence, age and sex distribution, location, clinicat signs and symptoms, pathology, genetics and prédictive factors. The book, prepared by more than 130 authors from 24 countries, contains about 1000 colour photographs, numerous charts and more than 2,500 references. |
Note de contenu : |
Contents WHO Classification Summary table Introduction to the classification of tumours of haematopoietic and lymphoid tissues 1 Introduction and overview of the classification of the myeloid neoplasms 2 Myeloproliferative neoplasms Chronic myelogenous leukaemia, BCR-ABL1 positive Chronic neutrophilic leukaemia Polycythaemia vera Primary myelofibrosis Essential thrombocythaemia Chronic eosinophilic leukaemia, NOS Mastocytosis Cutaneous mastocytosis Systemic mastocytosis Mast cell leukaemia Mast cell sarcoma Extracutaneous mastocytoma Myeloproliferative neoplasm, unclassifiable 3 Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1 4 Myelodysplastic/myeloproliferative neoplasms Chronic myelomonocytic leukaemia Atypical chronic myeloid leukaemia, BCR-ABL1 negative Juvenile myelomonocytic leukaemia Myelodysplastic/myeloproliferative neoplasm, unclassifiable 5 Myelodysplastic syndromes Myelodysplastic syndromes/neoplasms, overview Refractory cytopenia with unilineage dysplasia Refractory anaemia with ring sideroblasts Refractory cytopenia with multilineage dysplasia Refractory anaemia with excess blasts Myelodysplastic syndrome with isolated del(5q) Myelodysplastic syndrome, unclassifiable Childhood myelodysplastic syndrome Refractory cytopenia of childhood 6 Acute myeloid leukaemia (AML) and related precursor neoplasms AML with recurrent genetic abnormalities AML with t(8;21)(q22;q22); RUNX1-RUNX1T1 AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11 Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA AML with t(9;11)(p22;q23); MLLT3-MLL AML with t(6;9)(p23;q34); DEK-NUP214 AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1 AML (megakaryoblastic) with t(1;22)(p13;q13); RBM15-MKL1 9 AML with mutated NPM1 120 10 AMLwith mutated CEBPA 122 AML with myelodysplasia-related changes 124 14 Therapy-related myeloid neoplasms 127 Acute myeloid leukaemia, NOS 130 AML with minimal differentiation 130 17 AML without maturation 131 AML with maturation 131 31 Acute myelomonocytic leukaemia 132 32 Acute monoblastic and monocytic leukaemia 133 38 Acute erythroid leukaemia 134 40 Acute megakaryoblastic leukaemia 136 44 Acute basophilic leukaemia 137 48 Acute panmyelosis with myelofibrosis 138 51 Myeloid sarcoma 140 54 Myeloid proliferations related to Down syndrome 142 57 Transient abnormal myelopoiesis 142 58 Myeloid leukaemia associated with 61 Down syndrome 143 61 Blastic plasmacytoid dendritic cell neoplasm 1 45 61 64 7 Acute leukaemias of ambiguous lineage 149 Acute undifferentiated leukaemia 151 Mixed phenotype acute leukaemia with t(9;22)(q34;q11.2); BCR-ABL 1 151 67 Mixed phenotype acute leukaemia with t(v;11q23); MLL rearranged 152 75 Mixed phenotype acute leukaemia, B/myeloid, NOS 152 76 Mixed phenotype acute leukaemia, T/myeloid, NOS 153 80 Mixed phenotype acute leukaemia, NOS - rare 82 types 154 Other ambiguous lineage leukaemias 155 85 Natural killer (NK)-cell lymphoblastic leukaemia/lymphoma 155 87 88 8 Introduction and overview of the classification of 94 the lymphoid neoplasms 157 96 98 9 Precursor lymphoid neoplasms 167 100 B lymphoblastic leukaemia/lymphoma, NOS 168 102 B lymphoblastic leukaemia/lymphoma 103 with recurrent genetic abnormalities 171 104 B lymphoblastic leukaemia/lymphoma with 104 t(9:22)(q34;q 11.2); BCR-ABL1 171 B lymphoblastic leukaemia/lymphoma with t(v;11q23); MLL rearranged 171 109 B lymphoblastic leukaemia/lymphoma with 110 t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1) 172 110 B lymphoblastic leukaemia/lymphoma with hyperdiploidy 173 111 B lymphoblastic leukaemia/lymphoma with hypodiploidy (Hypodiploid ALL) 174 112 B lymphoblastic leukaemia/lymphoma with 114 t(5;14)(q31;q32); 174 115 B lymphoblastic leukaemia/lymphoma with t(1;19) (q23;p13.3); E2A-PBX1(TCF3-PBX1) 175 116 T lymphoblastic leukaemia/lymphoma 176 117 |
Exemplaires
Code-barres | Cote | Support | Localisation | Section | Disponibilité |
---|---|---|---|---|---|
M029906 | M4031 | Livre | Salle de consultation sur place | Livres Anglais | Exclu du prêt |
M029907 | M4031 | Livre | Salle de prêt | Livres Anglais | Disponible |